STOCK TITAN
  1. Home
  2. News
  3. UTMD

Utah Medical Products, Inc. - UTMD STOCK NEWS

Welcome to our dedicated news page for Utah Medical Products (Ticker: UTMD), a resource for investors and traders seeking the latest updates and insights on Utah Medical Products.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Utah Medical Products's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Utah Medical Products's position in the market.

News
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
Rhea-AI Summary
Utah Medical Products, Inc. reported financial performance for the first quarter of 2024, showing a decrease in revenues, gross profit, operating income, net income, and earnings per share compared to the same period in 2023. Despite lower sales both domestically and internationally, the company managed to maintain a strong balance sheet with no debt, ending with $93.8 million in cash and investments. The decline in gross profit was attributed to manufacturing overhead costs not decreasing proportionately to the sales decline, although the gross profit margin was higher than expected due to a favorable product mix and improved labor productivity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products, Inc. (UTMD) has announced a 1.7% increase in its quarterly cash dividend to thirty cents per share of common stock. The dividend is payable on April 3, 2024, to stockholders of record at the close of business on March 15, 2024. The company specializes in health care for women and babies, manufacturing and marketing disposable and reusable specialty medical devices recognized globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
dividends
-
News
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
Rhea-AI Summary
Utah Medical Products, Inc. (UTMD) achieved financial results for the full year of 2023 consistent with management’s beginning of year projections. Revenues were 4% lower, with net income and earnings per share 1% higher than in 2022. Operating income, income before tax, and gross profit margins were down in 2023 compared to 2022. However, net income and earnings per share margins were higher in 2023, despite lower consolidated worldwide sales. UTMD's balance sheet remained strong, with cash and investments of $92.9 million on December 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
none
News
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
Rhea-AI Summary
Utah Medical Products, Inc. (Nasdaq:UTMD) has announced a quarterly cash dividend of $0.30 per share of common stock, payable on January 3, 2024. This represents a 1.7% increase over the previous dividend. Utah Medical Products is a leading company in the healthcare industry, specializing in medical devices for women and babies. They develop, manufacture, and market disposable and reusable specialty medical devices used by clinicians in over a hundred countries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
dividends
-
News
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
Rhea-AI Summary
Utah Medical Products, Inc. achieved financial results for 9M 2023 consistent with projections. Revenues decreased by 3% in 3Q 2023 compared to 3Q 2022. Gross profit decreased by 10% and operating income decreased by 23% in 3Q 2023. Net income increased by 4% in 9M 2023. The company's cash balance increased by $3.62 per outstanding share. Domestic sales were lower, while international sales were higher.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
none
-
News
UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S.
Rhea-AI Summary
Utah Medical Products, Inc. provides an update on the status of Filshie product liability lawsuits. Five lawsuits with a total of 54 claimants have been dismissed. Twelve lawsuits with 63 new claimants remain open. CEO Kevin Cornwell expresses confidence in defending the reputation of the Filshie clip System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
none
News
Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products, Inc. (NASDAQ:UTMD) announced a 1.7% increase in their quarterly cash dividend, now at $.295 per share, payable on October 3, 2023. The company specializes in health care for women and babies, manufacturing medical devices used globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
dividends
-
News
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
Rhea-AI Summary
Utah Medical Products, Inc. (UTMD): Achieved 2Q and 1H 2023 financial results consistent with projections. Despite lower sales, 1H gross profit margin improved, resulting in almost the same total gross profit. Operating Income declined due to unusual litigation expenses, but Net Income for 1H 2023 was up 10% compared to 1H 2022. Key financial figures and margins are detailed in the PR, highlighting the company's performance and challenges.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
none
-
News
Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
dividends
News
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
Stock UTMD logo
Utah Medical Products, Inc.

Nasdaq:UTMD

UTMD Rankings

#3610 Ranked by Market Cap
#2953 Ranked by Stock Gains
#1484 Ranked by Dividends

UTMD Stock Data

246.42M
3.15M
6.52%
72.75%
1.54%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Midvale

About UTMD

utah medical products, inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in hundreds of countries around the world as the standard for obtaining optimal long term outcomes for their patients. for more information about utah medical products, inc., visit utmd’s website at www.utahmed.com.